๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lung Cancer
Clinical trial register · Canada

Lung Cancer Trials in Canada, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 6540 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:55 UTC
6540
Studies in scope
all four open statuses
3515
Recruiting now
open to new participants
887
Lead sponsors
across recruiting studies
Top sites
Toronto 17 Hamilton 6 Ottawa 6 Montreal 5 Vancouver 5
Narrow the registerReset
Recruitment status
Phase
Site location
Toronto17 Hamilton6 Ottawa6 Montreal5 Vancouver5
All 19 locations
Target enrolment
to

Lung Cancer trials in Canada

28 of 6540 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Not yet open
Totally Robotic Versus Surgeon-Assisted Robotic Lung Resection For Early-Stage NSCLC
NCT06348030Lung Cancer
St. Joseph's Healthcare Hamilton
Not applicable
120
Hamilton
2026-09
Recruiting
Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
NCT07524114Breast Cancer, Lung Cancer, Melanoma, Gynecologic Cancer
University Health Network, Toronto
Observational
7,000
Toronto
2026-03-31
Active, closed
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
NCT07128199Lung Cancer, Adjuvant, Post-surgical, EGFR
Taiho Oncology, Inc.
Phase 3
360
Edmonton, Brampton, London, Toronto
2025-12-22
Recruiting
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT06618287Lung Cancer, Breast Cancer
Bristol-Myers Squibb
Phase 1/2
416
Edmonton, Newmarket, Ottawa, Montreal
2025-02-04
Recruiting
Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease
NCT05986318Lung Cancer, Interstitial Lung Disease
David Palma
Phase 2
98
Vancouver, Saint John, London, Montreal
2025-01-07
Recruiting
Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer
NCT05849129Lung Cancer
The Canadian College of Naturopathic Medicine
Phase 2
90
Ottawa
2024-10-01
Recruiting
A Registry for People With Lung Cancer
NCT06424327Lung Cancer, Lung Cancer Stage I
Memorial Sloan Kettering Cancer Center
Observational
600
Toronto, Montreal
2024-05-15
Active, closed
The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person
NCT05509751Lung Cancer, Gastro-intestinal Cancer, Genito-Urinary Cancer, Breast Cancer
Martine Puts
Not applicable
60
Toronto
2023-10-01
Recruiting
Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) Study
NCT06628102Lung Cancer, Pulmonary Nodule
British Columbia Cancer Agency
Not applicable
3,600
Vancouver
2023-08-04
Active, closed
Optimizing Endobronchial Ultrasound Sampling for Molecular Markers for NSCLC
NCT05560776Lung Cancer, Non Small Cell Lung Cancer, Circulating Tumor Cell
Institut universitaire de cardiologie et de pneumologie de Quรฉbec, University Laval
Not applicable
120
Quรฉbec
2023-05-01
Recruiting
NSCLC Liquid Biopsies and Exhaled VOC
NCT06707519Lung Cancer, Circulating Tumor DNA
St. Joseph's Healthcare Hamilton
Observational
210
Hamilton
2023-02-01
Recruiting
The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III
NCT04871412Lung Cancer, Gastric Cancer, Esophageal Cancer
Ottawa Hospital Research Institute
Phase 3
20
Ottawa, Toronto
2022-04-04
Active, closed
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
NCT04968548Lung Cancer
Nucleix Ltd.
Observational
5,000
Calgary, Vancouver, Toronto, Montreal
2021-09-17
Recruiting
Talazoparib and Thoracic RT for ES-SCLC
NCT04170946Lung Cancer, Small-Cell Lung Cancer
University Health Network, Toronto
Phase 1
24
Toronto
2020-10-05
Recruiting
Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery
NCT04459065Lung Cancer
University of Saskatchewan
Phase 1/2
36
Saskatoon
2020-09-01
By invitation
Ex-Vivo COF Study for Lung Cancer Observation
NCT04534413Lung Cancer
University Health Network, Toronto
Observational
50
Toronto
2020-08-05
Recruiting
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
NCT04273061Breast Cancer, Lung Cancer, Gastrointestinal Cancer, Genitourinary Cancer
British Columbia Cancer Agency
Phase 2
50
Vancouver, Toronto
2020-06-17
Active, closed
Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer
NCT04093167Lung Cancer
Canadian Cancer Trials Group
Phase 2/3
53
Edmonton, Vancouver, Greater Sudbury, Hamilton, Kingston, Ottawa, Sault Ste. Marie, Toronto
2020-05-26
Recruiting
Pan-Canadian Lung Cancer Observational Study (PALEOS)
NCT04706754Lung Cancer
William Osler Health System
Observational
25,000
Brampton
2020-04-07
Recruiting
Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)
NCT04235114Lung Cancer, Colorectal Cancer
University of Saskatchewan
Phase 1/2
14
Saskatoon
2020-02-01
Active, closed
Palliative Thoracic ImmunoRT
NCT03705806Lung Cancer, Nonsmall Cell, Lung Cancer
University Health Network, Toronto
Observational
12
Toronto
2018-10-03
Recruiting
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
NCT03702309Cancer, Breast Cancer, Lung Cancer, Colon Cancer
University Health Network, Toronto
Observational
2,500
Toronto
2017-08-03
Recruiting
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
NCT02906943Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma
University Health Network, Toronto
Observational
10,000
Hamilton, Kingston, London, Ottawa, Toronto
2016-08
Active, closed
18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer
NCT02701699Lung Cancer
University Health Network, Toronto
Not applicable
36
Toronto
2014-12
Recruiting
Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer
NCT01487603Lung Cancer
University Health Network, Toronto
Observational
400
Toronto
2011-10
Active, closed
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
NCT00499330Lung Cancer
Alliance for Clinical Trials in Oncology
Not applicable
โ€”
Surrey, Moncton, Halifax, Hamilton, London, Ottawa, Toronto, Montreal
2007-10-12
Rows per page Showing 1–28 of 28
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-canada/condition/lung-cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,540 studies in total at the last sync on 26 Sep 2026, 19:55 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 28 of those studies listing the condition Lung Cancer.

How many Lung Cancer trials are recruiting in Canada?

18 of the 28 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:55 UTC sync. A further 1 have not yet opened recruitment, 8 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lung Cancer), 28 studies
PhaseStudiesRecruitingShare
Observational10735.7%
Not applicable8328.6%
Phase 1/23310.7%
Phase 23310.7%
Phase 3217.1%
Phase 1113.6%
Phase 2/3103.6%

Most active sponsors

Lead sponsors with the most studies (Lung Cancer)
Lead sponsorStudiesRecruiting
University Health Network, Toronto96
British Columbia Cancer Agency22
St. Joseph's Healthcare Hamilton21
University of Saskatchewan22
Alliance for Clinical Trials in Oncology10
Bristol-Myers Squibb11
Canadian Cancer Trials Group10
David Palma11
Institut universitaire de cardiologie et de pneumologie de Quรฉbec, University Laval10
Martine Puts10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.